Using data mining to characterize DNA mutations by patient clinical features
In most hereditary cancer syndromes, finding a correspondence between various genetic mutations within a gene (genotype) and a patient's clinical cancer history (phenotype) is challenging; to date there are few clinically meaningful correlations between specific DNA intragenic mutations and cor...
Gespeichert in:
Veröffentlicht in: | Proceedings - AMIA Annual Fall Symposium 1997, p.253-257 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 257 |
---|---|
container_issue | |
container_start_page | 253 |
container_title | Proceedings - AMIA Annual Fall Symposium |
container_volume | |
creator | Evans, S Lemon, S J Deters, C Fusaro, R M Durham, C Snyder, C Lynch, H T |
description | In most hereditary cancer syndromes, finding a correspondence between various genetic mutations within a gene (genotype) and a patient's clinical cancer history (phenotype) is challenging; to date there are few clinically meaningful correlations between specific DNA intragenic mutations and corresponding cancer types. To define possible genotype and phenotype correlations, we evaluated the application of data mining methodology whereby the clinical cancer histories of gene-mutation-positive patients were used to define valid or "true" patterns for a specific DNA intragenic mutation. The clinical histories of patients with their corresponding detailed attributes without the same oncologic intragenic mutation were labeled incorrect or "false" patterns. The results of data mining technology yielded characterizing rules for the true cases that constituted clinical features which predicted the intragenic mutation. Some of the initial results derived correlations already independently known in the literature, adding to the confidence of using this methodological approach. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2233315</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79388906</sourcerecordid><originalsourceid>FETCH-LOGICAL-p329t-20f8b9276cbaf88ed8f5e246acf56e2fdad6cff725e66ba412ff2f37984d00ef3</originalsourceid><addsrcrecordid>eNpVkM1LAzEQxXNQaq3-CUJO3haySTebXIRSP6HoxZ7DbHbSRvbLJCvUv94Vi-hpHryZ33vMCZnnTOeZ4oqdkfMY3xiTOcvljMy0KErJyznZbKPvdrSGBLT13bdOPbV7CGATBv-J9PZ5RdsxQfJ9F2l1oMMksUvUNtOBhYY6hDQGjBfk1EET8fI4F2R7f_e6fsw2Lw9P69UmGwTXKePMqUrzUtoKnFJYK1cgX0qwrpDIXQ21tM6VvEApK1jm3DnuRKnVsmYMnViQmx_uMFYt1nYqE6AxQ_AthIPpwZv_Tuf3Ztd_GM6FEHkxAa6PgNC_jxiTaX202DTQYT9GU2qhlGZyWrz6m_Qbcfyf-ALl824X</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79388906</pqid></control><display><type>article</type><title>Using data mining to characterize DNA mutations by patient clinical features</title><source>MEDLINE</source><source>PubMed Central</source><creator>Evans, S ; Lemon, S J ; Deters, C ; Fusaro, R M ; Durham, C ; Snyder, C ; Lynch, H T</creator><creatorcontrib>Evans, S ; Lemon, S J ; Deters, C ; Fusaro, R M ; Durham, C ; Snyder, C ; Lynch, H T</creatorcontrib><description>In most hereditary cancer syndromes, finding a correspondence between various genetic mutations within a gene (genotype) and a patient's clinical cancer history (phenotype) is challenging; to date there are few clinically meaningful correlations between specific DNA intragenic mutations and corresponding cancer types. To define possible genotype and phenotype correlations, we evaluated the application of data mining methodology whereby the clinical cancer histories of gene-mutation-positive patients were used to define valid or "true" patterns for a specific DNA intragenic mutation. The clinical histories of patients with their corresponding detailed attributes without the same oncologic intragenic mutation were labeled incorrect or "false" patterns. The results of data mining technology yielded characterizing rules for the true cases that constituted clinical features which predicted the intragenic mutation. Some of the initial results derived correlations already independently known in the literature, adding to the confidence of using this methodological approach.</description><identifier>ISSN: 1091-8280</identifier><identifier>PMID: 9357627</identifier><language>eng</language><publisher>United States: American Medical Informatics Association</publisher><subject>Age of Onset ; Algorithms ; BRCA2 Protein ; Breast Neoplasms - epidemiology ; Breast Neoplasms - genetics ; Family ; Female ; Genes, BRCA1 ; Humans ; Mathematical Computing ; Mutation ; Neoplasm Proteins - genetics ; Ovarian Neoplasms - epidemiology ; Ovarian Neoplasms - genetics ; Software ; Transcription Factors - genetics</subject><ispartof>Proceedings - AMIA Annual Fall Symposium, 1997, p.253-257</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2233315/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2233315/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,4024,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9357627$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Evans, S</creatorcontrib><creatorcontrib>Lemon, S J</creatorcontrib><creatorcontrib>Deters, C</creatorcontrib><creatorcontrib>Fusaro, R M</creatorcontrib><creatorcontrib>Durham, C</creatorcontrib><creatorcontrib>Snyder, C</creatorcontrib><creatorcontrib>Lynch, H T</creatorcontrib><title>Using data mining to characterize DNA mutations by patient clinical features</title><title>Proceedings - AMIA Annual Fall Symposium</title><addtitle>Proc AMIA Annu Fall Symp</addtitle><description>In most hereditary cancer syndromes, finding a correspondence between various genetic mutations within a gene (genotype) and a patient's clinical cancer history (phenotype) is challenging; to date there are few clinically meaningful correlations between specific DNA intragenic mutations and corresponding cancer types. To define possible genotype and phenotype correlations, we evaluated the application of data mining methodology whereby the clinical cancer histories of gene-mutation-positive patients were used to define valid or "true" patterns for a specific DNA intragenic mutation. The clinical histories of patients with their corresponding detailed attributes without the same oncologic intragenic mutation were labeled incorrect or "false" patterns. The results of data mining technology yielded characterizing rules for the true cases that constituted clinical features which predicted the intragenic mutation. Some of the initial results derived correlations already independently known in the literature, adding to the confidence of using this methodological approach.</description><subject>Age of Onset</subject><subject>Algorithms</subject><subject>BRCA2 Protein</subject><subject>Breast Neoplasms - epidemiology</subject><subject>Breast Neoplasms - genetics</subject><subject>Family</subject><subject>Female</subject><subject>Genes, BRCA1</subject><subject>Humans</subject><subject>Mathematical Computing</subject><subject>Mutation</subject><subject>Neoplasm Proteins - genetics</subject><subject>Ovarian Neoplasms - epidemiology</subject><subject>Ovarian Neoplasms - genetics</subject><subject>Software</subject><subject>Transcription Factors - genetics</subject><issn>1091-8280</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkM1LAzEQxXNQaq3-CUJO3haySTebXIRSP6HoxZ7DbHbSRvbLJCvUv94Vi-hpHryZ33vMCZnnTOeZ4oqdkfMY3xiTOcvljMy0KErJyznZbKPvdrSGBLT13bdOPbV7CGATBv-J9PZ5RdsxQfJ9F2l1oMMksUvUNtOBhYY6hDQGjBfk1EET8fI4F2R7f_e6fsw2Lw9P69UmGwTXKePMqUrzUtoKnFJYK1cgX0qwrpDIXQ21tM6VvEApK1jm3DnuRKnVsmYMnViQmx_uMFYt1nYqE6AxQ_AthIPpwZv_Tuf3Ztd_GM6FEHkxAa6PgNC_jxiTaX202DTQYT9GU2qhlGZyWrz6m_Qbcfyf-ALl824X</recordid><startdate>1997</startdate><enddate>1997</enddate><creator>Evans, S</creator><creator>Lemon, S J</creator><creator>Deters, C</creator><creator>Fusaro, R M</creator><creator>Durham, C</creator><creator>Snyder, C</creator><creator>Lynch, H T</creator><general>American Medical Informatics Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>1997</creationdate><title>Using data mining to characterize DNA mutations by patient clinical features</title><author>Evans, S ; Lemon, S J ; Deters, C ; Fusaro, R M ; Durham, C ; Snyder, C ; Lynch, H T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p329t-20f8b9276cbaf88ed8f5e246acf56e2fdad6cff725e66ba412ff2f37984d00ef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Age of Onset</topic><topic>Algorithms</topic><topic>BRCA2 Protein</topic><topic>Breast Neoplasms - epidemiology</topic><topic>Breast Neoplasms - genetics</topic><topic>Family</topic><topic>Female</topic><topic>Genes, BRCA1</topic><topic>Humans</topic><topic>Mathematical Computing</topic><topic>Mutation</topic><topic>Neoplasm Proteins - genetics</topic><topic>Ovarian Neoplasms - epidemiology</topic><topic>Ovarian Neoplasms - genetics</topic><topic>Software</topic><topic>Transcription Factors - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Evans, S</creatorcontrib><creatorcontrib>Lemon, S J</creatorcontrib><creatorcontrib>Deters, C</creatorcontrib><creatorcontrib>Fusaro, R M</creatorcontrib><creatorcontrib>Durham, C</creatorcontrib><creatorcontrib>Snyder, C</creatorcontrib><creatorcontrib>Lynch, H T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings - AMIA Annual Fall Symposium</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Evans, S</au><au>Lemon, S J</au><au>Deters, C</au><au>Fusaro, R M</au><au>Durham, C</au><au>Snyder, C</au><au>Lynch, H T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Using data mining to characterize DNA mutations by patient clinical features</atitle><jtitle>Proceedings - AMIA Annual Fall Symposium</jtitle><addtitle>Proc AMIA Annu Fall Symp</addtitle><date>1997</date><risdate>1997</risdate><spage>253</spage><epage>257</epage><pages>253-257</pages><issn>1091-8280</issn><abstract>In most hereditary cancer syndromes, finding a correspondence between various genetic mutations within a gene (genotype) and a patient's clinical cancer history (phenotype) is challenging; to date there are few clinically meaningful correlations between specific DNA intragenic mutations and corresponding cancer types. To define possible genotype and phenotype correlations, we evaluated the application of data mining methodology whereby the clinical cancer histories of gene-mutation-positive patients were used to define valid or "true" patterns for a specific DNA intragenic mutation. The clinical histories of patients with their corresponding detailed attributes without the same oncologic intragenic mutation were labeled incorrect or "false" patterns. The results of data mining technology yielded characterizing rules for the true cases that constituted clinical features which predicted the intragenic mutation. Some of the initial results derived correlations already independently known in the literature, adding to the confidence of using this methodological approach.</abstract><cop>United States</cop><pub>American Medical Informatics Association</pub><pmid>9357627</pmid><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1091-8280 |
ispartof | Proceedings - AMIA Annual Fall Symposium, 1997, p.253-257 |
issn | 1091-8280 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2233315 |
source | MEDLINE; PubMed Central |
subjects | Age of Onset Algorithms BRCA2 Protein Breast Neoplasms - epidemiology Breast Neoplasms - genetics Family Female Genes, BRCA1 Humans Mathematical Computing Mutation Neoplasm Proteins - genetics Ovarian Neoplasms - epidemiology Ovarian Neoplasms - genetics Software Transcription Factors - genetics |
title | Using data mining to characterize DNA mutations by patient clinical features |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T06%3A24%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Using%20data%20mining%20to%20characterize%20DNA%20mutations%20by%20patient%20clinical%20features&rft.jtitle=Proceedings%20-%20AMIA%20Annual%20Fall%20Symposium&rft.au=Evans,%20S&rft.date=1997&rft.spage=253&rft.epage=257&rft.pages=253-257&rft.issn=1091-8280&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E79388906%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79388906&rft_id=info:pmid/9357627&rfr_iscdi=true |